YCBD
cbdMD, Inc. (AMEX)
Healthcare — Drug Manufacturers - Specialty & Generic
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.
Price History
Fundamentals
| Market Cap | $7.14M |
| P/E Ratio (TTM) | 0.28 |
| Forward P/E | -0.76 |
| EPS (TTM) | $2.46 |
| Dividend Yield | - |
| Profit Margin | -13.29% |
| Revenue Growth | 18.80% |
| ROE | -53.39% |
| Debt/Equity | 4.47 |
| Recommendation | None |
| Analyst Target | $2.00 |
| Analysts | 1 |
| Indexes | AMEX |
Technical Indicators
| RSI (14) | 47.5 |
| Beta | 2.13 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $2.56 |
| 52-Week Low | $0.47 |
| 50-Day Avg | $0.78 |
| 200-Day Avg | $0.87 |
| Avg Volume | 969.4K |
| Volume | 70.1K |
Performance Analysis
NEUTRALYCBD presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:38 UTC
Back to Screener Export Report